Pierga, J., Bidard, F., Autret, A., Petit, T., Andre, F., Dalenc, F., Levy, C., Ferrero, J., Romieu, G., Bonneterre, J., Lerebours, F., Bachelot, T., Kerbrat, P., Campone, M., Eymard, J., Mouret-Reynier, M., Gligorov, J., Hardy-Bessard, A., Lortholary, A., Soulie, P., Boher, J., Proudhon, C., Charafe-Jaufret, E., Lemonnier, J., Bertucci, F., & Viens, P. (2017). circulating tumour cells and pathological complete response: independent prognostic factors in inflammatory breast cancer in a pooled analysis of two multicentre phase II trials (BEVERLY-1 and -2) of neoadjuvant chemotherapy combined with bevacizumab. Annals of oncology, 28, 103–109. http://access.bl.uk/ark:/81055/vdc_100126094932.0x000037